(917) 310-3371
Confirm OSA
Review the sleep report, severity, oxygen findings, symptoms, study quality, and current treatment.
Sleep and medical weight management | New York
Obesity and sleep apnea treatment in New York
A coordinated pathway for adults who have both conditions, without treating weight loss as a substitute for sleep evaluation or prescribed airway therapy.
Start with evaluation, not a product assumption
The care team must confirm clinical fit, current records, monitoring, access, and the correct site before treatment moves forward.
Direct answer
Obesity and obstructive sleep apnea often affect each other, but each needs a clear diagnosis and treatment plan. For adults with obesity and confirmed moderate-to-severe OSA, the current Zepbound label includes treatment with reduced-calorie diet and increased physical activity. Other patients may need a different weight-treatment approach. Positive airway pressure, oral-appliance, surgical, and sleep-specialist care remain separate decisions.
Current product and service status
This pathway is for adults who have both obesity and confirmed obstructive sleep apnea. Patients without a confirmed diagnosis should begin with sleep evaluation and appropriate testing.
Start with the right diagnosis
Weight and sleep symptoms can guide evaluation, but they do not replace a diagnostic sleep study.
Assess weight-related health
Review weight history, blood pressure, diabetes, cardiovascular risk, medicines, mobility, sleep schedule, and prior treatment.
Identify urgent safety needs
Severe sleepiness, drowsy driving, major oxygen concerns, or unstable cardiopulmonary disease may require expedited sleep or specialty care.
Coordinate treatments instead of choosing one
The care plan should address airway obstruction and metabolic health together.
Continue effective airway treatment
Do not stop CPAP or another prescribed OSA treatment just because weight treatment begins.
Build an evidence-based weight plan
Nutrition, activity, behavioral support, medicine, and bariatric referral can be considered according to clinical need and patient preference.
Reassess after meaningful change
Weight change may alter OSA severity or device needs, but repeat testing or treatment changes should be directed by the sleep-care team.
Where Zepbound fits
The FDA indication is specific and should not be broadened to every person who snores or has obesity.
Labeled population
Zepbound is approved for moderate-to-severe OSA in adults with obesity, along with reduced-calorie diet and increased physical activity.
Not a diagnostic medicine
A prescription should not be used to bypass sleep testing or to infer an OSA diagnosis.
Not the only pathway
Another weight treatment or non-medication plan may fit better based on safety, goals, response, access, and preference.
How the evaluation moves forward
The sequence protects safety and keeps a product request from bypassing diagnosis, records, monitoring, access, or referral needs.
Review goals and history
The clinician reviews weight history, prior treatment, current medicines, related conditions, pregnancy plans when relevant, and the patient's goals.
Assess clinical fit
The visit addresses label criteria, contraindications, interactions, side effects, nutrition, activity, and whether another treatment path is more appropriate.
Plan access and teaching
If a prescription is appropriate, the team discusses the dosage form, administration instructions, coverage process, and follow-up. Approval and supply are not guaranteed.
Reassess over time
Follow-up considers response, tolerability, adherence, dose changes, related conditions, and whether treatment should continue or change.
Evaluation locations across New York
Choose a nearby Nao Medical clinic as a starting point for evaluation or care coordination.
Capability boundary: these location cards do not establish that a medicine, device, laboratory test, injection, or specialty workflow is available at every site. Confirm the exact service before travel.
Bronx
174th Street
932 E 174th St, Bronx, NY 10460
A place to begin evaluation and care coordination near West Farms, Crotona Park East, and nearby Bronx neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A place to begin evaluation and care coordination near Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Bronx
Bartow Mall
2063A Bartow Ave, Bronx, NY 10475
A place to begin evaluation and care coordination near Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Brooklyn
Crown Heights
341 Eastern Pkwy, Brooklyn, NY 11216
A place to begin evaluation and care coordination near Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Long Island
Hicksville
232 W Old Country Rd, Hicksville, NY 11801
A place to begin evaluation and care coordination near Hicksville, Plainview, Bethpage, and nearby Nassau County communities. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Jackson Heights
80-10 Northern Blvd, Jackson Heights, NY 11372
A place to begin evaluation and care coordination near Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Jamaica
90-18 Sutphin Blvd, Jamaica, NY 11435
A place to begin evaluation and care coordination near Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Queens
Long Island City
30-07 36th Ave, Astoria, NY 11106
A place to begin evaluation and care coordination near Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Long Island
Mineola
135 Mineola Blvd, Mineola, NY 11501
A place to begin evaluation and care coordination near Mineola, Garden City, Westbury, and nearby Nassau County communities. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Manhattan
StuyTown
259 1st Ave, New York, NY 10003
A place to begin evaluation and care coordination near StuyTown, the East Village, Gramercy, and nearby Manhattan neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Brooklyn
Williamsburg
308 Graham Ave, Brooklyn, NY 11211
A place to begin evaluation and care coordination near Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods. Call first to confirm the right visit. This card does not confirm product stock, testing, teaching, dispensing, or administration capability.
Related care and next steps
Compare focused options, prepare for an evaluation, and connect medication questions with broader care.
Zepbound
Review dosing, devices, safety, access, and the labeled OSA population.
Sleep apnea evaluation and home sleep testing
Start here when OSA is suspected but not confirmed.
Medical weight loss
Explore Nao Medical's broader weight-management program and treatment options.
Wegovy injection
Review a different weight-treatment product under its own label.
Primary care
Use ongoing primary care to connect medication decisions with the rest of your health history.
Frequently asked questions
Answers reflect current official sources and Nao Medical's limited evaluation and coordination scope.
Obesity is a major OSA risk factor, but anatomy, age, and other factors also matter. A diagnostic evaluation is still required.
Yes, for moderate-to-severe obstructive sleep apnea in adults with obesity, together with reduced-calorie diet and increased physical activity.
No. Continue prescribed treatment unless the sleep-care clinician changes the plan after reassessment.
The labeled OSA pathway requires confirmed moderate-to-severe OSA. Bring the diagnostic report and current treatment information.
No outcome is guaranteed. Some patients improve, while others continue to need OSA treatment. Severity should be reassessed clinically.
Weight treatment may improve OSA in some patients, but the specific FDA medication indication described here belongs to Zepbound for adults with obesity and moderate-to-severe OSA.
Bring the sleep-study report, PAP or device data when available, medication list, weight and treatment history, and records for diabetes, blood pressure, heart, or lung conditions.
Official sources
These sources support product identity, approval, current labeling, availability, and clinical boundaries. They do not prove Nao Medical site capability or health-plan coverage.
Zepbound prescribing information
Current adult obesity and moderate-to-severe OSA indication, dose, contraindications, and safety information.
Open official sourceFDA approves first medication for obstructive sleep apnea
Exact OSA population, diet and activity context, and approval evidence.
Open official sourceClinical practice guideline for diagnostic testing for adult obstructive sleep apnea
Diagnostic testing boundaries and need for comprehensive sleep evaluation.
Open official sourceSource and label check completed August 1, 2026. Named clinical and operations review is still pending.
Connect the evaluation to specific treatment pathways
Diagnosis and long-term care stay anchored in a full condition evaluation. The focused medication, testing, and service information below helps patients compare next steps without replacing that evaluation.
Home sleep testing
Confirm whether a home sleep apnea test or a different diagnostic pathway is appropriate.
Zepbound weight management
Review the separate weight-management pathway, contraindications, and coverage questions.
Medical weight loss
Connect sleep symptoms with a broader metabolic and longitudinal care plan.
Health information notice
General information only. The information here is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.